Page last updated: 2024-08-18

pyrazolanthrone and hoe 33342

pyrazolanthrone has been researched along with hoe 33342 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, G; Gu, B; Gu, PY; Hu, WX; Huang, JY; Li, JY; Li, M; Ren, KW; Wei, D; Xing, B; Zhang, GF	1

Other Studies

1 other study(ies) available for pyrazolanthrone and hoe 33342

Article	Year
SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest. Die Pharmazie, 2012, Volume: 67, Issue:11 Topics: Anthracenes; Benzimidazoles; Blotting, Western; Brain Neoplasms; CDC2 Protein Kinase; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Flow Cytometry; Fluorescent Dyes; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; M Phase Cell Cycle Checkpoints; MAP Kinase Kinase 4; Vacuoles	2012

Article

Year

SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest.

Die Pharmazie, 2012, Volume: 67, Issue:11

Topics: Anthracenes; Benzimidazoles; Blotting, Western; Brain Neoplasms; CDC2 Protein Kinase; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Flow Cytometry; Fluorescent Dyes; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; M Phase Cell Cycle Checkpoints; MAP Kinase Kinase 4; Vacuoles

2012